CO6751281A2 - Células b. texasporus deficientes de esporulación y métodos para inactivación eficiente y rentable y su uso - Google Patents

Células b. texasporus deficientes de esporulación y métodos para inactivación eficiente y rentable y su uso

Info

Publication number
CO6751281A2
CO6751281A2 CO13204350A CO13204350A CO6751281A2 CO 6751281 A2 CO6751281 A2 CO 6751281A2 CO 13204350 A CO13204350 A CO 13204350A CO 13204350 A CO13204350 A CO 13204350A CO 6751281 A2 CO6751281 A2 CO 6751281A2
Authority
CO
Colombia
Prior art keywords
sporulation
methods
deficient
texasporus
cells
Prior art date
Application number
CO13204350A
Other languages
English (en)
Inventor
Yiwei Jiang
Original Assignee
Mygalaxy Ltd Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mygalaxy Ltd Company filed Critical Mygalaxy Ltd Company
Publication of CO6751281A2 publication Critical patent/CO6751281A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)

Abstract

Se proporcionan nuevas cepas y métodos para su uso. Particularmente, alimentos y otros productos o tratamientos orales que contengan cepas Brevibacillus deficientes de esporulación cuando se administra a un sujeto pueden inhibir o reducir el número de patógenos en el sujeto y mejorar la salud del mismo.
CO13204350A 2011-03-01 2013-08-28 Células b. texasporus deficientes de esporulación y métodos para inactivación eficiente y rentable y su uso CO6751281A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161447703P 2011-03-01 2011-03-01
US13/406,202 US8673290B2 (en) 2011-03-01 2012-02-27 Sporulation-deficient B. texasporus cells and methods for efficient and cost-effective inactivation and use thereof

Publications (1)

Publication Number Publication Date
CO6751281A2 true CO6751281A2 (es) 2013-09-16

Family

ID=46753436

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13204350A CO6751281A2 (es) 2011-03-01 2013-08-28 Células b. texasporus deficientes de esporulación y métodos para inactivación eficiente y rentable y su uso

Country Status (15)

Country Link
US (3) US8673290B2 (es)
EP (2) EP2681338B1 (es)
JP (1) JP5970483B2 (es)
KR (1) KR20140015356A (es)
CN (2) CN105567587A (es)
AR (1) AR088715A1 (es)
AU (1) AU2012223481B2 (es)
BR (1) BR112013021892B1 (es)
CA (1) CA2828541C (es)
CL (1) CL2013002370A1 (es)
CO (1) CO6751281A2 (es)
MX (1) MX350277B (es)
RU (1) RU2013137673A (es)
WO (1) WO2012118845A1 (es)
ZA (1) ZA201306276B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104780931B (zh) * 2012-12-17 2018-05-18 星系有限公司 Bt脂肽作为用于肥胖和相关疾病的治疗剂的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302544A (en) 1979-10-15 1981-11-24 University Of Rochester Asporogenous mutant of B. subtilis for use as host component of HV1 system
US4450236A (en) 1982-04-21 1984-05-22 Cpc International Inc. Asporogenic mutant of Bacillus subtilis useful as a host in a host-vector system
US4450235A (en) 1982-04-21 1984-05-22 Cpc International Inc. Asporogenic mutant of bacillus subtilis useful as a host in a host-vector system
US4465773A (en) 1982-04-21 1984-08-14 Cpc International Inc. Amylase-negative, asporogenous mutant of Bacillus subtilis useful as a host in a host-vector system
US5480641A (en) 1990-06-15 1996-01-02 Biogaia Ab Feed additive which consists of whey and Lactobacillus reuteri and a method of delivering Lactobacillus reuteri to the gastrointestinal tract
IT1244477B (it) * 1990-12-21 1994-07-15 Eniricerche Spa Ceppo asporigeno di bacillus subtilis e suo impiego come ospite per la preparazione di prodotti eterologhi
CA2523711A1 (en) 2003-04-28 2004-11-11 Alpharma, Inc. Method for formulation of microbial feed additives with feed
US7655452B1 (en) 2003-11-11 2010-02-02 Higeta Shoyu Co., Ltd. Brevibacillus choshinensis and process for prodcuing protein wtih use of the microbe as host
BRPI0507186A (pt) * 2004-01-30 2007-06-26 Texas A & M Univ Sys composição, métodos e usos para uma nova famìlia de peptìdeos
JP2010220539A (ja) * 2009-03-24 2010-10-07 Tosoh Corp 胞子形成能が欠損した細菌、及びそれを用いたタンパク質製造方法

Also Published As

Publication number Publication date
AU2012223481A1 (en) 2013-08-29
RU2013137673A (ru) 2015-04-10
CN103732734A (zh) 2014-04-16
US20120225037A1 (en) 2012-09-06
AU2012223481B2 (en) 2016-06-30
JP5970483B2 (ja) 2016-08-17
CA2828541C (en) 2020-04-21
KR20140015356A (ko) 2014-02-06
CL2013002370A1 (es) 2014-04-04
MX2013009993A (es) 2013-12-06
EP3002340A1 (en) 2016-04-06
ZA201306276B (en) 2016-07-27
EP2681338A1 (en) 2014-01-08
EP2681338B1 (en) 2015-11-25
BR112013021892A2 (pt) 2016-09-06
WO2012118845A1 (en) 2012-09-07
AR088715A1 (es) 2014-07-02
CN103732734B (zh) 2016-01-20
CA2828541A1 (en) 2012-09-07
US8673290B2 (en) 2014-03-18
JP2014512807A (ja) 2014-05-29
US20140162343A1 (en) 2014-06-12
BR112013021892B1 (pt) 2021-01-05
CN105567587A (zh) 2016-05-11
MX350277B (es) 2017-08-30
US20140199753A1 (en) 2014-07-17

Similar Documents

Publication Publication Date Title
UY34678A (es) Administración de objetos en una cadena de suministro, mediante el empleo de un identificador segur o
MX2021008901A (es) Compuestos conjugados antisentido y su uso.
CL2014002757A1 (es) Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer.
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
CL2012001950A1 (es) Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
UY34750A (es) ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
MX352556B (es) Productos para el cuidado oral que comprenden óxido de zinc y trimetilglicina.
AR085943A1 (es) Composicion antimicrobiana
MX366368B (es) Metodos para el cuidado oral prebiotico usando un sacarido.
EA201390799A1 (ru) Триазолопиридины
CR20120494S (es) Empaque blister para producto
MX2013013649A (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
AR082215A1 (es) Composicion farmaceutica agradable al paladar
AR094224A1 (es) Composicion farmaceutica en forma de una suspension oral
AR105095A1 (es) Concentrado de jugo de fruta para una marinada
CR20120166A (es) Composiciones y productos antimicrobianos
CO6751281A2 (es) Células b. texasporus deficientes de esporulación y métodos para inactivación eficiente y rentable y su uso
CA145117S (en) Toothbrush packaging
MX368416B (es) Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis.
吕吉尔 Killing One Owl Species to Save Another
RU2011104901A (ru) Способ использования лечебных свойств "гриба" medusomuces gistvii в приготовлении экстрактов лекарственных растений
RU2011100853A (ru) Астаксантин для стоматологических средств
UA68905U (ru) Соединение 1,1'-(2"-бром-2"-хлорэтенил)-бис-(бензимидазол), имеющий противоопухолевые свойства
BR202012010039U8 (pt) Esterilizador contínuo
RU2012149676A (ru) Способ лечения телят, больных симулиидотоксикозом